2013 HESI Annual Meeting

The ILSI Health and Environmental Sciences Institute (HESI) held its 2013 Annual Meeting on 11-13 June 2013 at the Hotel Monaco, 480 King Street, Alexandria, Virginia, USA.

Meeting participants learned about HESI’s role in translating science from research to application, shared perspectives on current and pending scientific challenges, and engaged in interactive discussions that will help influence HESI’s future scientific direction.

Program Book for the 2013 HESI Annual Meeting

• Tab 1 - Meeting Agenda
• Tab 2 - HESI Assembly
• Tab 3 - Assembly Nominations
• Tab 4 - Emerging Issues Session
• Tab 5 - Speaker Bios
• Tab 6 - Participants List
• Tab 7 - About HESI
• Tab 8 - Success Stories

Annual Meeting Presentations

Scientific Program Session: HESI’s Role in Translating Science from Research to Application

Bridging Science for Improved Immunotoxicity Evaluation
Dr. Ellen Evans (Pfizer)

Translational Approaches in Cardiovascular Safety
Dr. Brian Berridge (GlaxoSmithKline)

Best Practices for Sustainable Alternative Chemical Substitutions
Dr. George Gray (George Washington University)

Plenary Lecture

Strategic Directions for EPA’s Research
Dr. Hal Zenick (US Environmental Protection Agency, National Health and Environmental Effects Research Laboratory)

HESI Assembly Meeting

HESI Assembly
Dr. Dennis Devlin (Exxon Mobil Corporation)
Ms. Syril Pettit (HESI Executive Director)

HESI CITE Keynote Lecture

Biomaterials and Biotechnology: From the Development of Controlled Drug Delivery Systems to the Foundation of Tissue Engineering
Dr. Robert Langer (Massachusetts Institute of Technology)

Lunchtime Seminar

Open Access and Publishing: The New Frontier in Science?
Ms. Heather Joseph (Scholarly Publishing and Academic Resources Coalition)

Emerging Issues Session

HESI Emerging Issues Session: Looking Around the Corner
Dr. Stephen Newsholme (GlaxoSmithKline)

Strategic Enhancement of the HESI Scientific Portfolio
Dr. Hal Zenick (US Environmental Protection Agency, National Health and Environmental Effects Research Laboratory)
Dr. Stephen Newsholme (GlaxoSmithKline)

Plenary Discussion
Dr. Stephen Newsholme (GlaxoSmithKline)
Dr. Hal Zenick (US Environmental Protection Agency, National Health and Environmental Effects Research Laboratory)